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The capacity to produce therapeutically relevant quantities of
multipotent mesenchymal stromal cells (MSCs) via in vitro culture
is a common prerequisite for stem cell-based therapies. Although
culture expanded MSCs are widely studied and considered for
therapeutic applications, it has remained challenging to identify
a unique set of characteristics that enables robust identification
and isolation of the multipotent stem cells. New means to describe
and separate this rare cell type and its downstream progenitor
cells within heterogeneous cell populations will contribute signifi-
cantly to basic biological understanding and can potentially improve
efficacy of stem and progenitor cell-based therapies. Here, we use
multivariate biophysical analysis of culture-expanded, bone mar-
row-derived MSCs, correlating these quantitative measures with
biomolecular markers and in vitro and in vivo functionality. We find
that, although no single biophysical property robustly predicts stem
cell multipotency, there exists a unique and minimal set of three
biophysical markers that together are predictive of multipotent
subpopulations, in vitro and in vivo. Subpopulations of culture-
expanded stromal cells from both adult and fetal bone marrow
that exhibit sufficiently small cell diameter, low cell stiffness, and
high nuclear membrane fluctuations are highly clonogenic and
also exhibit gene, protein, and functional signatures of multi-
potency. Further, we show that high-throughput inertial micro-
fluidics enables efficient sorting of committed osteoprogenitor
cells, as distinct from these mesenchymal stem cells, in adult bone
marrow. Together, these results demonstrate novel methods and
markers of stemness that facilitate physical isolation, study, and
therapeutic use of culture-expanded, stromal cell subpopulations.
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The biophysical state of a cell is potentially a rich source ofinformation indicative of cell identity and physiology. When
the underlying biochemical activity that occurs as cells replicate,
senesce, differentiate, become malignant, or undergo apoptosis
is manifest as measurable changes in biophysical characteristics,
then parameters such as cell size or mechanical stiffness (1–4)
may serve as predictive markers of cellular fate. For example, the
metastatic competence of cancer cell lines has been correlated
with average mechanical creep compliance (5, 6), and the stiff-
ness of malaria-infected (7) and sickle red blood cells (8) has
been related to disease stage and severity.
The successful application of mechanobiology to the analysis
of human disease has prompted development of biophysical
cytometry methods to study the functional multipotency of stem
cells (9, 10). However, such efforts to predict multipotency or
“stemness” are challenging due to potential coupling or plurality
of biophysical changes in response to distinct cues. For example,
changes in cell size are not only related to cell cycle events (11)
and cell proliferation rates (12), but also to the reported dif-
ferentiation capacity of progenitor cells derived from corneal
epithelium (13), adipose tissue (14), or adult bone marrow (15,
16). It is thus evident that a more comprehensive physical profile
of stem cells is required to consider whether biophysical markers
are robust indicators of inducible function in vitro and in vivo.
Herein, we demonstrate that multivariate biophysical analysis of
cells can readily identify subpopulations of multipotent, as well
as osteochondral progenitor, cells within in vitro culture-
expanded mesenchymal stromal cells (MSCs).
Although often referred to and treated as a uniform stem cell
population, culture-expanded MSCs derived from adult bone
marrow (aMSCs) are actually a heterogeneous cell mixture (16,
17). These cell populations exhibit reduced multilineage poten-
tial during in vitro culture expansion (18, 19). This decreased
multipotency has been attributed to environmental cues (20–25)
during in vitro culture and results in MSC subpopulations that
render it difficult to study and engineer “stem cell behavior.”
Such desirable behavior includes self-renewal and multilineage
differentiation in vitro or production of uniform, robust thera-
peutic responses in vivo. However, the long-term and large-scale
expansion of aMSCs is necessary to obtain a clinically rele-
vant number of cells for many envisioned tissue regeneration
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therapies. Conventional high-throughput sorting of multi-
potent MSCs from this heterogeneous, putative MSC population
via flow cytometry has proven insufficient, due to the lack of bio-
molecular surface markers that select specifically for multipotency
(15, 26, 27); such molecular labeling approaches also restrict via-
bility and use of such cells for therapeutic applications (28). Thus, it
is common to verify the multipotency of MSC subpopulations or
clones via in vitro experiments that directly quantify MSC capacity
to form colonies and differentiate along multiple tissue lineages.
These Schrodinger’s cat-like assessments of viable stem cell function
are both retrospective and confer obvious limitations for robust
studies of stem cell biology and for clinical applications of culture-
expanded MSCs. Such considerations illustrate the need for
alternative, multivariate, and functional cytometry platforms and
methods that can identify marrow stromal cell subpopulations
of predictable potency or progenitor status, without labeling or
differentiating those cells.
Here, we quantify several biophysical characteristics of MSCs
subpopulations derived from human adult and fetal bone mar-
row. These potential multivariate biomarkers of MSC potency
are as follows: (i) suspended cell diameter; (ii) adherent cell
spread area; (iii) cell stiffness; (iv) nuclear to cytoplasmic ratio;
and (v) relative nuclear membrane fluctuations. We correlated
each property with molecular surface markers, in vitro multi-
lineage differentiation potential, and in vivo regenerative po-
tential (see SI Appendix for discussion of previous studies that
noted one or more of these properties to be potential indicators
of differentiation capacity or commitment). Of particular in-
terest is whether any of these physical signatures, or combina-
tions thereof, could prospectively identify and sort multipotent
MSC subpopulations from precommitted progenitor cells. We find
that cell size is a necessary but insufficient predictor of MSC mul-
tipotency: not all subpopulations of small diameter are multipotent,
as might be inferred from previous in vitro studies that compared
smaller and larger MSCs (16). Among the several other biophysical
markers considered, we find that only cell stiffness and nuclear
fluctuations correlated strongly with in vitro differentiation potential
and in vivo bone and muscle regeneration capacity. Specifically,
adult and fetal MSC subpopulations of sufficiently low mean di-
ameter (D < 20 μm), low mechanical stiffness (E < 375 Pa), and
high nuclear fluctuations (NF > 1.2%) consistently exhibited mul-
tipotency in vitro and in vivo. All other MSC subpopulations ex-
hibited commitment toward the osteogenic lineage. Together these
findings suggest a minimal set of biophysical markers exist for the
identification of MSC and progenitor subpopulations toward clini-
cal applications.
Results
One or multiple biophysical characteristics may serve as a suffi-
cient set to identify stem cells of predictable potency. However,
a comprehensive assessment of these potential biophysical mark-
ers for prospective in vitro and in vivo outcomes remains lacking.
Below, we consider correlations of multipotency with each of
these potentical biophysical markers, starting with cell diameter.
As human bone marrow-derived MSCs demonstrate differentia-
tion behavior that depends strongly on both culture conditions and
donor source (29), we considered 10 donor sources (5 adult donor
sources, denoted aD1–aD5, and 5 fetal donor sources, denoted
fD1–fD5) under identical in vitro culture conditions.
Size-Based Microfluidic Sorting. aMSCs are known to exhibit het-
erogeneity in size and loss of multipotency when expanded in
culture (30, 31); in contrast, fetal MSCs (fMSCs) remain con-
sistently small in size and are reported to be multipotent even
after extended in vitro expansion (32). Thus, given our own
observations and previous qualitative reports that smaller aMSCs
proliferate more rapidly and appear similar to fMSCs in adher-
ent cell morphology, we first considered whether cell size was
strongly correlative with MSC phenotype and differentiation
potency. This analysis was enabled by size-based sorting of sus-
pended cells in a microfabricated inertial microfluidic spiral
channel device (33) (Fig. 1A), into multiple outlet streams (here,
outlets 1, 2, 3, and 4) of decreasing cell diameter. This high-
throughput sorting system can fractionate up to >107 cells/h, sig-
nificantly exceeding that reported previously for other microfluidics-
based methods and enabling us to isolate MSC subpopulations with
sufficient efficiency, quantity, and cell viability (>90%) (33) re-
quired of subsequent biophysical characterization and biochemical
assays. This method is detailed in SI Appendix.
Table 1 shows the mean suspended cell diameter for size-
sorted subpopulations from each donor; from donor aD1, for
example, cells collected from outlet 1 were of mean cell diameter
D = 25.5 ± 0.5 μm and from outlet 4 were of D = 17.8 ± 0.2 μm.
Among all adult donors, MSC subpopulations of largest D were
consistently collected in outlet 1 (25.7 ± 0.7 μm, termed hereafter
as Dhi > 20 μm) and showed minimal overlap in size with sub-
populations of smallest mean cell diameter, which were collected
in outlet 4 (16.8 ± 0.3 μm, termed hereafter as Dlo). Although the
population fraction varied among donors, these subpopulations
(outlets 1 and 4) represent ∼15% and ∼20% of the entire un-
sorted cell population at passage 5 (P5), respectively. The Dhi and
Dlo aMSC subpopulations were used for subsequent experiments
for each donor source in this study, and their corresponding un-
sorted aMSCs from the same donor were used as controls. In
contrast, fMSCs exhibited less dispersion in cell diameter (∼16 μm,
Dlo) and could not be further fractionated into size-based sub-
populations. SI Appendix, Fig. S1 provides these data graphically
and shows visually apparent differences in the adherent cell size for
Dhi and Dlo sorted subpopulations.
Cell Size Is Not Wholly Predictive of Multipotency. To consider
whether cell size is a necessary and sufficient biophysical marker
of stemness, we first tested the correlation between the sus-
pended cell diameter and in vitro multipotency. Following size-
based sorting, cells were adhered to tissue culture polystyrene
(TCPS) for 24 h before multilineage differentiation potential
(adipo-, osteo-, chondro-, and myogenesis) was assessed via estab-
lished assays. Differentiation positivity and extent were determined
by spectrophotometric quantification of lineage-specific metabolite
production toward the adipogenic, osteogenic, or chondrogenic
lineages on chemical induction of differentiation in vitro; myogenic
differentiation was assessed using immunostaining for desmin-
expressing cells. Differentiation was considered to have occurred
(i.e., differentiation positivity was noted) for subpopulations that
produced metabolites or percentage immunopositive greater
than the 90th percentile of the noninduced negative controls (SI
Appendix, Fig. S2); this provided an objective determination of
potency (14) that was independent of the extent of differentia-
tion as discussed further in SI Appendix, Fig. S2. SI Appendix,
Figs. S3 and S4 provide representative images from in vitro
differentiation for adult and fetal MSCs, respectively, that were
a subset of data in SI Appendix, Fig. S2. Subpopulations that
showed differentiation toward either three or four of these lin-
eages (adipo-, osteo-, chondro-, and myogenic) were noted as
multipotent, whereas subpopulations that exhibited commitment
toward either two or one lineage were considered as bipotent and
unipotent, respectively. Notably, across all adult and fetal donors
screened, bipotent groups were only able to differentiate along
both the osteogenic and chondrogenic lineages. No subpop-
ulation was unipotent or showed a total lack of differentiation
capacity, in contrast to previous reports of bone marrow-derived
MSC clones exhibiting very low prevalence of adipo-chondro,
adipo-osteo, and unipotent phenotypes (34); this may be attrib-
uted to low prevalence of those phenotypes in nonclonal cultures.
Table 1 illustrates that all aMSC subpopulations of large di-
ameter (Dhi aMSCs) were bipotent (osteogenic and chondrogenic),
2 of 10 | www.pnas.org/cgi/doi/10.1073/pnas.1402306111 Lee et al.
three of the five small-diameter subpopulations (Dlo aMSCs) were
multipotent, and three of the five fMSC donors were multipotent.
The relative potency of Dhi vs. Dlo subpopulations for aMSCs and
for fMSCs was consistent at different cell passage numbers (pop-
ulation doublings), as tabulated in SI Appendix, Table S1 for both
passages 5 and 8 (see SI Appendix, Tables S1 and S2 for data and
discussion of how shifts in subpopulation prevalence can change
the apparent potency of an unsorted MSC population over mul-
tiple passages). Spearman’s correlation analysis was used to de-
termine the strength and significance level of correlation between
the potency and mean cell diameter of each subpopulation of
MSCs. The correlation between cell size and multipotency was not
strong (r = −0.551, P = 0.033;Methods and SI Appendix, Table S3).
Thus, as cell size alone was an insufficient biophysical predictor
of multipotency, we next considered whether one or more other
properties (cell stiffness, nuclear fluctuations, cell spread area, and
relative nuclear-to-cytoplasm ratio) would together define the
multipotent MSC subpopulations.
Cell Stiffness and Nuclear Membrane Fluctuations Correlate with
Multipotency. fMSCs and size-sorted aMSC subpopulations were
seeded onto tissue culture polystyrene and allowed to attach and
spread before subsequent characterization of mechanical stiffness
E and nuclear fluctuations NF. Physical sorting into Dhi and Dlo
subpopulations did not detectably alter these properties and was
used because this significantly increased the efficiency of these
next biophysical, in vitro, and in vivo assays of each subpopulation
defined in part by cell diameter. SI Appendix, Fig. S5 shows that
distributions of measured D, E, and NF were similar, with and
without passage of cells through the microfluidic device.
We characterized the mechanical response of attached cells
via atomic force microscopy-enabled nanoindentation of the
cell body. These measurements provide an effective Young’s
elastic modulus E of the cell (Methods and SI Appendix, Fig.
S9), and we refer to this quantity as cell stiffness. Mean stiff-
ness E is reported in Fig. 2 as probability distributions, con-
structed using statistical bootstrapping from 30 to 60 replicate
measurements (i.e., cells) for each donor and each sub-
population (35) (Methods). Fig. 2 A and B shows the cell
stiffness profile of the Dhi aMSCs, Dlo aMSCs, and fMSCs
from all donor samples. On the high end of the spectrum, the
mean stiffness of Dhi aMSCs ranged from 460.3 ± 31.0 to
1,100 ± 99.6 Pa among five donors as shown in Table 1
(mean ± SEM). These larger cells were significantly stiffer
than the Dlo aMSCs (E = 329.6 ± 43.8 Pa for the same five
donors) and fMSCs (E = 321.3 ± 31.4 Pa for five donors).
Subsequent correlation analyses showed that cell stiffness
varied negatively with cell potency (r = −0.787, P < 0.01;
Fig. 1. Schematic of study. (A) aMSCs are heterogeneous in size and were first size sorted using a microfabricated spiral microchannel into four fractions
(outlets 1, 2, 3, and 4) of decreasing cell diameter. Subpopulations of largest diameter (outlet 1; ∼25 μm, Dhi) and subpopulations of smallest diameter (outlet 4;
∼16 μm, Dlo) were used for subsequent experiments for each donor source; the corresponding unsorted aMSCs from the same donor (∼21 μm) were used as
the control. fMSCs exhibit less dispersion in size (∼16 μm, Dlo) and could not be further fractionated as a function of diameter. (B) After size separation, the Dlo
and Dhi MSC subpopulations were further characterized in terms of cell stiffness, relative nuclear fluctuation, cell spread area, and nucleus-to-cytoplasm ratio.
(C) Biophysical markers from each MSC subpopulation were then correlated with in vitro differentiation capacity along four lineages: fat, bone, cartilage, and
muscle, and also with in vivo bone growth and muscle repair summarized in Fig. 5.
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SI Appendix, Table S3). Specifically, we observed that MSCs
from both adult and fetal sources that exhibited E > 375 Pa also
exhibited osteochondral biopotency, regardless of whether these
stiffer groups were categorized as Dlo or Dhi subpopulations. SI
Appendix, Fig. S5B shows that E of these subpopulations was not
detectably altered by first sorting subpopulations by cell diameter.
This observation that stiffer, uninduced MSCs exhibit limited
potency and osteogenic commitment is consistent with other related
works that showed the tendency of attached and undifferentiated
stem cells to become stiffer during differentiation (36) or in com-
parison with osteoblasts (23). For example, Gonzalez-Cruz et al.
recently demonstrated positive correlation between stiffness of at-
Table 1. Biophysical markers from different subpopulations of MSCs
D (suspended cell diameter), E (effective cell elastic modulus), NF (relative nuclear fluctuations), N:C (nuclear to cytoplasmic ratio), and A (attached cell
spread area). Data are presented as mean ± SEM for passage 5. Corresponding population potency of biophysical triplets described by D, E, and NF is also
indicated in green (multipotent: adipo-, osteo-, chondro-, and myogenic,) or red (bipotent: osteo-, chondrogenic), respectively. Mean D, E, and NF corre-
sponding to values below (for D and E) and above (for NF) bipotency thresholds discussed in the text are indicated in green and otherwise are red.
A
C
B
D
Fig. 2. Cell stiffness and relative nuclear fluctuation correlate with potency of putative MSCs. Thresholds of effective mean elastic modulus E and average
nuclear fluctuations NF were determined experimentally by comparing these mechanical properties of all donor subpopulations sampled against the in vitro
multilineage differentiation potential. Multipotent MSC subpopulations exhibited a consistent biophysical phenotype: sufficiently low cell diameter (50), low
mechanical stiffness (Elo), and high relative nuclear fluctuation (NFhi) (color-coded green). In contrast, subpopulations that did not meet this criterion (i.e.,
those that were either large or of high mechanical stiffness or of low relative nuclear fluctuation) were only bipotent (color-coded red). (A) Large or Dhi MSCs
from all adult donors were bipotent and exhibited an average E >375 Pa. (B) Similarly, small or Dlo MSCs of E > 375 Pa (aD4 and fD4) were also bipotent. In
contrast, multipotent Dlo MSCs were consistently more compliant with E < 375 Pa. (C) Dhi MSCs from all adult donors exhibited an average NF of <1.2%, which
is in contrast to the (D) multipotent Dlo MSCs that typically exhibited NF > 1.2%. Notably, Dlo MSCs that were bipotent (aD5 and fD5) also exhibited NF <1.2%,
suggesting that among the many biophysical parameters considered herein, multipotency is characterized minimally by three biophysical criteria (DloEloNFhi).
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tached, adipose-derived stem cells (n = 19–25 cells from 32 clones)
and in vitro osteogenic differentiation (14). Although there is a clear
link between cell stiffness and osteogenicity, we found that not all
mechanically compliant subpopulations with E < 375 Pa were
multipotent: aD5 Dlo and fD5 Dlo donor cells were strongly oste-
ogenic in terms of relative extent of bone mineral production (SI
Appendix, Figs. S2–S4 for comparisons of alizarin red intensity).
This finding indicates that, like cell diameter, cell stiffness alone is
also not wholly predictive of stem cell multipotency, and motivates
a threshold stiffness of attached MSCs beyond which robust
multipotency is not expected. Thus far in our consideration of
biophysical markers, the above results show that Dhi MSC sub-
populations are consistently stiff and bipotent, and Dlo MSC
subpopulations are either stiff and bipotent or compliant and
multipotent.
We next considered whether functional differences among the
Dhi and Dlo subpopulations of MSCs could be correlated with
physical fluctuations of the nuclear lamin scaffold. This candi-
date biophysical marker is motivated by analyses of mouse em-
bryonic stem cells (ESCs), which Bhattacharya et al. showed to
exhibit greater nuclear fluctuations than mouse embryonic fibro-
blasts; this increased nuclear membrane fluctuation or “nuclear
fluidity” has been related to the extent and rate of chromatin
rearrangement within the nucleus (37). In the present study, MSCs
from each donor were size sorted and adhered for 12 h before
transfection with EGFP-tagged nuclear membrane protein lamin
B1 (EGFP-LaminB1) and subsequent analysis via time-lapsed
confocal microscopy (Methods). The relative nuclear fluctuations
were quantified in terms of changes in the projected nuclear area
(<δAr ≥
P
δAri/n) over all time points (7 min) as a measure of
relative nuclear fluidity (see Methods and SI Appendix, Fig. S10
for calculation details). Larger or DhiMSCs generally exhibited
lower relative nuclear fluctuation NF (0.90 ± 0.02% to 1.12 ±
0.02%, mean ± SEM), whereas DloMSCs from adult or fetal
donors tended to exhibit higher NF as shown in Table 1 (and SI
Appendix, Table S1). SI Appendix, Fig. S5C shows that NF of
these subpopulations was not detectably altered by first sorting
subpopulations by cell diameter.
Correlation analyses revealed that MSC potency was generally
correlated positively with NF (r = 0.852, P < 0.05; SI Appendix,
Table S3), independently of cell diameter. As in the case of cell
stiffness, threshold segmentation was observed to be able to
distinguish multipotent and progenitor subpopulations: Fig. 2 C
and D shows that subpopulations of lower NF (<1.2%) were
bipotent and exhibited only osteo-chondrogenic differentiation
potential. Note that this observation of the restricted potencies
in subpopulations of low NF included those of small cell di-
ameter (Dlo aD5 and fD5), which were not predicted previously
by cell stiffness measurements. However, considerations of the
NF magnitude alone were also not wholly predictive of multi-
potency for MSCs exhibiting higher NF (>1.2%). In fact, Dlo aD4
and fD4 subpopulations were bipotent and exhibited high NF;
however, these MSCs also exhibited cell stiffness exceeding the
threshold E of ∼375 Pa that correlated with bipotent Dhi MSCs
subpopulations. These findings in human MSCs are consistent
with recent studies (37, 38) that demonstrated that terminally
differentiated primary mouse embryonic fibroblasts exhibit less
dynamic nuclear organization than undifferentiated mouse
ESCs; those nuclear area fluctuations correlated with higher
chromatin dynamics (38). These higher fluctuations of chromatin
and nuclear area NF in the stem cell nuclei are interpreted as
a functional capacity of chromosomes to reconfigure in the un-
differentiated state (39).
Thus, in our consideration of these three candidate biophysical
markers, none can singly be wholly predictive of multipotency.
However, we found that cell populations that are small and
mechanically compliant and exhibit higher nuclear membrane
fluctuations are also consistently multipotent. Next, let us con-
sider two additional candidate markers of multipotency, also
motivated by qualitative analogy to pluripotent ESCs.
Cell Spread Area and Nucleus:Cytoplasm Ratio Do Not Correlate with
Multipotency. The projected contact area between cells and tissue
culture polystyrene (i.e., cell spread area A), as well as the vol-
umetric ratio of the cell nucleus to cytoplasm (N:C), of adherent
MSCs was measured via fluorescence staining and confocal
analysis. We identified no detectable correlation (SI Appendix,
Table S3) between attached cell spread area and potency state
(r = −0.134, P > 0.1) or between N:C ratio and potency state
(r = −0.245, P > 0.1) in MSCs. We note that others have ob-
served that the N:C ratios of undifferentiated ESCs decrease sig-
nificantly during lineage commitment (40) and that correlation exists
betweenN:C and stiffness/multipotency of suspended stem cells (41).
In our studies, we intentionally maintained subconfluent cell cultures
as discussed by Sekiya et al. (29) to minimize the uncharacteristically
increased cell spreading as cells approach confluency.
A Minimal Set of Biophysical Markers of Stem Cell Multipotency.
Overall, these findings suggest the need for multivariate bio-
physical characterization, as is also often required for robust
biomolecular characterization of phenotype via antigen labeling.
These results reveal a minimal set of biophysical markers that are
indicative of a cell subpopulation’s differentiation potency: cell
diameter D, cell stiffness E, and relative nuclear fluctuations NF.
To consider and denote this, we assigned fixed thresholds of each
parameter to describe subpopulations of MSCs in biophysical
marker categories, reminiscent of relative expression levels of
biochemical markers of phenotype. The four resulting cate-
gories of putative MSCs are DloEloNFhi, DloEloNFlo, DloEhiNFhi,
and DhiEhiNFlo (Fig. 3 A–P). SI Appendix, Table S4 quantifies the
percentage difference in D, E and NF subpopulations from the
same donor source; on average, for a given donor the larger (Dhi)
subpopulations were of 60% greater diameter, 150% higher
stiffness, and 25% lower nuclear fluctuations. Only culture-
expanded subpopulations of small diameter (D < 18 μm) that were
also compliant (E < 375 Pa) and exhibited highly dynamic nu-
clear lamina fluctuations (NF > 1.2%) were multipotent in vitro;
the biophysical description of these multipotent MSC sub-
populations is that they are DloEloNFhi cells. All other cate-
gories (cell subpopulations of sufficiently large diameter and/or
of sufficiently high stiffness or low nuclear fluctuations) were re-
stricted in potency to osteogenic and chondrogenic lineages and
were thus committed osteochondral progenitors (see SI Appen-
dix, Table S1 and Figs. S6 and S7 for the corresponding 3D
graphical depiction and property distributions of this multivari-
ate characterization of each subpopulation, respectively, and also
SI Appendix, Discussion for correlations between cell diameter
and the extent of osteogenic commitment as quantified by me-
tabolite production).
To further define the functional properties of stemness of each
category of MSCs, cells from each subpopulation were seeded via
limiting dilution into 96-well plates at one cell per well (n = 3
replicate experiments). Fig. 3Q shows that DloEloNFhi subpop-
ulations exhibited significantly more colony formation units
(CFUs) at 52 ± 3.2% compared with the other three MSC sub-
population categories (P < 0.05). These subpopulations also
exhibited a higher proliferation rate (Fig. 3R); see SI Appendix,
Fig. S11 for all donor sets. Our findings detailed in the discussion
below further indicate that this biophysical subpopulation de-
scription is a necessary and sufficient (compared with the larger
set of potential biophysical markers we considered) set of mark-
ers that we found to correlate with MSC subpopulation multi-
potency, genetically, and in vitro and in vivo.
We also note that this minimal set of biophysical markers does
not obviate the existence of additional biophysical markers of
stemness beyond the many analyzed here. This minimal biophysical
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marker set also does not obviate the potential for new biochemical
or biomolecular markers, including expression levels of known or
yet unidentified cell surface proteins or intracellular macro-
molecules that may also correlate strongly with this set of bio-
physical markers of MSC multipotency. Importantly, however,
the current set of biomolecular markers that are often used to test
for stem cell enrichment do not distinguish among these sub-
populations that exhibit clear biophysical and functional differ-
ences. SI Appendix, Fig. S8 shows that at least these frequently
used biomolecular markers failed to resolve differences by
DloEloNFhi DhiEhiNFloDloEhiNFhiDloEloNFlo
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Fig. 3. Multilineage differentiation of MSC subpopulations along (A–D) fat, (E–H) bone, (I–L) cartilage, and (M–P) muscle lineages in vitro. Only DloEloNFhi
MSCs were multipotent (>60%) and consistently exhibited differentiation along all four lineages (Q), whereas MSCs that exhibited either high stiffness (51) or
low nuclear fluctuation (NFlo) were limited to differentiation along only the osteogenic and chondrogenic lineages. (Scale bar, 50 μm.) The DloEloNFhi MSCs
also showed higher colony formation efficiency, CFU-F (Q), and higher proliferation rate (R).
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immunophenotyping among subpopulations that differed in
biophysical characteristics and in differentiation potency:
MSC subpopulations from all donor sources, both adult and
fetal, exhibited a consistent molecular surface marker pheno-
type that was negative for endothelial (CD31) and hemato-
poietic (C34 and CD45) markers and positive for putative
mesenchymal marker [CD105 (SH2)], and cell adhesion
molecules (CD90 and CD106).
Correlation of Cell Biophysical Markers with Gene Transcription and
Translation. To determine whether significant genetic differences
existed among these subpopulations and might be relevant to the
state of differentiation potency, we next compared the tran-
scriptional profile of the MSC subpopulations classified by bio-
physical markers. Fig. 4 A, i shows the heat map of a candidate
set of genes generated via microarray analysis. Notable expression
of genes such as CCL2, CCR2, IGFBP2, FOXO1, and SPOCK2
indicated osteogenic cell characteristics in the DhiEhiNFlo sub-
population; this finding is consistent with our observations in
functional differentiation assays and provides genetic evidence
that DhiEhiNFlo cells are osteogenically committed. For cell
populations characterized as DloEloNFhi, no evidence of lineage
commitment was evident from microarray analysis. However,
cross-referencing of data sets among MSC groups identified
a set of up-regulated transcripts (Fig. 4 A, ii) that were corre-
lated inversely with those of DhiEhiNFlo subpopulations. Four of
these genes (USP1, CCNL2, CXCL12, and PODXL) have been
implicated previously as important in the preservation of stem
cell fate, as well as in the maintenance of chromosomal structure
and activity (30, 42, 43). Although beyond the scope of the present
study to fully explore the role of these genes in the multipotency of
MSCs, the relative up-regulation of these genes in only the DloElo
NFhi subpopulation is consistent with the concept that this sub-
population is not lineage committed.
To verify that these biophysical markers also reliably catego-
rized the MSCs at the level of protein expression, we addition-
ally performed RT-PCR and immunocytochemistry. Transcripts
for proteins correlative with osteogenic differentiation (osteo-
pontin, Runx2, and late-stage marker ostocalcin) were expressed
differentially via RT-PCR (Fig. 4 B–D) and were most signifi-
cantly up-regulated in the DhiEhiNFlo group and down-regulated
in the DloEloNFhi group. Further, osteopontin and alkaline phos-
phatase were expressed differentially via immunocytochemical
staining (Fig. 4E). These findings are consistent with groupings
classified by biophysical markers. Specifically, only the DloEloNFhi
MSCs (from both fetal and adult marrow sources) exhibited pro-
tein expression consistent with in vitro differentiation toward
all three mesenchymal lineages, whereas the other subpop-
ulations showed decreased adipogenesis and enhanced osteogenic
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Fig. 4. Microarray heat map of relevant transcripts from a pool of >48,000 human transcripts on the Illumina HT-12 chip, showing differential expression of osteogenic
genes (A, i), as well as genes associated with maintenance of a stem cell program in MSCs (A, ii). These data demonstrate that biophysical cell characterization is an
effective means to prospectively identify MSCs that have different levels of lineage commitment. Comparative RT-PCR analysis of the osteogenic gene markers:
osteopontin (B), runx2 (C), and osteocalcin (D) in all MSC groups used in the study, normalized by the housekeeping gene GADPH. Significant up-regulation of these
important osteogenic markers in the DhiEhiNFlo further confirms that this is a subpopulation of osteogenically committed cells. Immunofluorescent staining of early
osteogenic markers, (E) alkaline phosphatase (ALP, red) and osteopontin (OPN, green), of MSC subpopulations classified under four categories of cell size, stiffness, and
nuclear fluctuations as discussed in the text. A representative subpopulation from each category is shown. All but the DloEloNFhi groups show elevated levels of ALP and
OPN, indicating that those subpopulations that are not described as DloEloNFhi exhibit some level of commitment toward the osteogenic lineage. (Scale bar, 100 μm.)
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differentiation potential. Further, the overall gene expression
pattern among the different MSC groups also demonstrates
that biophysical characterization of these cell populations is ef-
ficient for prospectively determining the state of MSC sub-
population differentiation potency.
Biophysical Markers Are Also Predictive of in Vivo End Points. After
verifying that the set of biophysical markers allowed characteriza-
tion of culture-expanded MSCs into different cell subpopulations
that exhibit a greater degree of functional homogeneity, we sought
to determine whether MSC subpopulations characterized in this
manner would result in more potent and reproducible therapeutic
effects in vivo. First, to evaluate whether these biophysical markers
can identify a particular subpopulation among putative MSCs that
exhibits a higher potential for bone tissue engineering applica-
tions (44), we seeded each porous osteoinductive polymer scaf-
fold [polycaprolactone-tricalcium phosphate (PCL-TCP) cubes of
5-mm edge length] with a cell subpopulation (or unsorted cells, as
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Fig. 5. (A–C) In vivo ectopic bone formation of the MSC biophysical categories within PCL-TCP scaffold constructs. Subpopulations from representative cell
donor sources are shown. (A) Representative X-ray images showing greater contrasts in scaffolds loaded with committed subpopulations (red) of MSCs: (A, i)
DhiEhiNFlo, (A, ii) DloEhiNFhi, and (A, iii) DloEloNFlo compared with the uncommitted DloEloNFhi MSCs (green). (B) Bone constructs extracted 4 wk after implan-
tation showed that the EloNFhi MSCs (both adult and fetal) accumulated the least osteosense fluorescent signal (*P < 0.05, two tailed) than the committed
subpopulations of MSCs (adult, P = 0.0048; fetal, P = 0.011), indicating a slower rate of osteogenesis in vivo. (C) Osteosense signal quantification revealed
enhanced mineralization in the committed subpopulations of MSCs (DhiEhiNFlo, DloEhiNFhi, and DloEloNFlo) compared with the uncommitted DloEloNFhi MSCs
groups from both adult and fetal donors. (D) In vivo myogenic differentiation potential of the different categories of MSCs. Subpopulations from representative
cell donor sources are shown. (D, i) Immunofluorescent staining of sectioned cardiotoxin-damaged skeletal muscle tissue, 3 wk after infusion with different MSC
populations, showed greater engraftment (green) and spectrin formation (red) for the DloEloNFhi MSCs. (D, ii) Similarly, greater engraftment and spectrin
formation was also observed in the DloEloNFhi groups in fetal MSCs (Table 1). (Scale bar: 10×, 100 μm; 20×, 50 μm.) Biophysical markers from different sub-
populations of MSCs. D (suspended cell diameter), E (effective cell elastic modulus), and NF (relative nuclear fluctuations). Corresponding population potency of
biophysical triplets described by D, E, and NF is also indicated in green (multipotent: adipo-, osteo-, chondro- and myogenic,) or red (bipotent: osteo-, chon-
drogenic), respectively.
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indicated) obtained from a single donor source. For example,
a scaffold seeded with aD1 DhiEhiNFlo cells comprised the size-
sorted subpopulation of larger cells from that donor source, and
those larger cells were also stiffer and of lower nuclear fluctuations.
All donor sets were included, and this represented all four bio-
physically distinct groups characterized by combinations of size, stiff-
ness, and nuclear fluctuations (DloEloNFhi, DloEloNFlo, DloEhiNFhi,
and DhiEhiNFlo), as well as nonseeded control scaffolds (Methods).
These scaffolds were implanted subcutaneously in the dorsum of a
single nonirradiated NOD/SCID mouse, and acellular PCL-TCP
scaffolds were implanted as a control with n = 5 mice per cell donor
source and corresponding subpopulation (44). The degree of ectopic
bone mineralization on the implanted constructs was evaluated and
quantified 4 wk after implantation using X-ray imaging and a sys-
temically injected hydroxyapatite-directed bone-imaging probe
(OsteoSense). X-ray imaging showed that the scaffolds containing
committed MSC groups (DloEloNFlo, DloEhiNFhi, and DhiEhiNFlo)
exhibited a greater extent of bone mineralization compared with the
uncommitted DloEloNFhi phenotype (Fig. 5A). These observations
were further confirmed by quantification of the accumulated osteo-
sense fluorescent signal from the implanted scaffolds (Fig. 5 B and C
and SI Appendix, Fig. S12 for all donors) and demonstrate that the
subpopulations that are determined to be osteoprogenitors (Dlo
EloNFlo, DloEhiNFhi, and DhiEhiNFlo) by our set of biophysical
markers also exhibit high efficacy for in vivo osteogenic tissue
regeneration. These results also show that a committed osteo-
progenitor subpopulation (DhiEhiNFlo) could be isolated consis-
tently from the putative adult MSCs based on size alone (Dhi),
using this high-throughput microfluidic device.
To further test this concept that biophysical markers are
predictive of in vivo response, we examined the capacity of the
different MSC subpopulations (as described above) to differen-
tiate and repair myogenic tissue after injury in NOD/SCID mice.
Although it is well established that the bone marrow-derived
MSCs are precursors of tissues of mesenchymal origin includ-
ing adipocytes, osteoblasts, and chondrocytes (45), others have
reported previously that MSCs that exhibit mesenchymal trili-
neage differentiation in vitro can show markers of myogenic
differentiation in vitro and in vivo (46, 47). This in vivo model for
myogenic tissue repair has been reported previously (48). Briefly,
4 h after cardiotoxin injection into the gastrocnemius skeletal
muscle, 30,000 MSCs were transplanted into the same region via
localized injection to allow regeneration of the cardiotoxin-
damaged skeletal muscle tissue. After a period of 20 d, the
degree of muscle regeneration by MSCs was evaluated by his-
tological examination. Fixed sections of the damaged muscles
were stained with a human specific antibodies to detect hu-
man tissue engraftment and myogenic differentiation. Histo-
logical examinations revealed that, in damaged muscle tissue
infused with both adult and fetal DloEloNFhi MSCs, extensive
clusters of discrete green fluorescent spectrin-expressing myofiber-
like tissues were present within the host muscle (Fig. 5 D, i and
ii). In contrast, the committed osteoprogenitor subpopulations
(DloEhiNFhi, DloEloNFlo, and DhiEhiNFlo) demonstrated limited
engraftment and minimal myogenic differentiation.
Discussion
Here, we considered different biophysical markers of stem cells
via methods that would enable robust identification and poten-
tial separation of committed progenitors from multipotent cells.
Our multivariate analysis shows that there exists a minimal set of
biophysical markers that can be used to determine MSC multi-
potency. Although large cell size (Dhi) consistently identifies
committed osteoprogenitors in adult MSCs, multilineage po-
tential (differentiation into adipo-, osteo-, chondro-, and myo-
genic lineages) is only observed if the cells are small, compliant,
and exhibit large nuclear membrane fluctuations (DloEloNFhi).
The committed MSC subpopulations have a greater propensity to
differentiate into osteoblasts and produce a greater extent of
mineralization than the uncommitted MSCs described by the
biophysical triplet, DloEloNFhi. Interestingly, these committed
subpopulations are not described uniquely by one biophysical
triplet, but by multiple triplets that share in common the
superthreshold magnitude of D and/or E and/or the subthreshold
magnitude of NF; this multiplicity of biophysical descriptors for
MSC-derived osteoprogenitors may reflect the multiplicity and
extended duration of phenotypic differentiation pathways. A
single device, the microfluidic spiral microchannel, is capable
of high throughput isolation of osteoprogenitor cells (Dhi cells),
which enables sorting of this subpopulation from marrow for
applications such as bone regeneration. Additional future bio-
physical markers may include those that enable direct physical
sorting of the solution suspended, multipotent DloEloNFhi cells.
Furthermore, although beyond the scope of this study (SI Appendix),
our approach could be extended to characterize the biophysical
parameters of cells from clonal populations, which could shed
further light on the mechanical ontogeny of MSCs after fewer
population doublings in vitro.
Overall, our data support the hypothesis that DloEloNFhi MSCs
are uncommitted, undifferentiated, clonogenic, and multipotent
precursor subpopulations in culture-expanded cells derived from
human bone marrow. Those biophysically distinct subpopulations
may emerge on culture expansion (17), and the prevalence of
such subpopulations can vary with donor or culture conditions.
We believe that this multivariate approach and set of validated
biophysical markers now offers the opportunity to identify and
select the subpopulation of the multipotent mesenchymal stromal
cells (or, alternatively, the osteoprogenitor cells) from heretofore
mixed populations of culture-expanded, putative stem cell pop-
ulations. This label-free method and analysis provide a necessary
precursor to the robust study, engineering, and many therapeutic
applications of these rare and valuable cells.
Methods
Cells analyzed herein were derived from bone marrow of five adult and five
fetal donors, each obtained from commercial or consortia sources of low-
passage putative MSCs (adult donors) or from established centrifugation and
plastic-adherence subculture methods (fetal donors) (49). These cell pop-
ulations from each donor source were thus considered to be mesenchymal
stem cells according to existing, accepted methods. Briefly, for each of the 10
donor sources, the cell diameter was quantified, and physical sorting into
cell size-specific subpopulations was achieved, by inertial microfluidic sorting
of suspended cells; cell stiffness was quantified via atomic force microscopy-
enabled nanoindentation of adhered living cells; and nuclear membrane
fluctuations were quantified via customized image analysis of cells trans-
fected to express fluorescent nuclear laminar proteins. Data discussed here
correspond to passage 5 (population doubling ∼10–12) for all donor sources
for consistency, and mean ± SEM unless otherwise noted. See SI Appendix
for detailed methods of biophysical characterization, in vitro and in vivo
assays, and data analysis.
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